STOCKS TELEGRAPH

Tag: Precipio Inc

  • 10 Of The Best Diagnostics Research Industry Stocks To Buy For 2020

    10 Of The Best Diagnostics Research Industry Stocks To Buy For 2020

    Healthcare is a dynamic and opportunity-rich industry. The demand for innovations that brings improvement in health outcomes, affordability, quality, and access will continue to be high. The changes we witnessed in the healthcare industry today have set a new tone for the change in the coming few years. 2020 is the year of change for the health care industry.

    The first thing which played an important role in the healthcare industry is Technology. Technology is continuously changing and brings new improvement in the healthcare industry. Patients today want easier and affordable access to care and better demand services. In this changing environment, diagnostics is emerging as a key driver in helping to address these needs.

    Here are the top 10 leading companies in Diagnostics Research Industry that need your attention:

    OPKO Health Inc. (NASDAQ: OPK)

    OPKO Health Inc. (NASDAQ: OPK) shares were trading down -0.92% at $3.22 at the time of writing on Tuesday. OPKO Health Inc. (NASDAQ: OPK) share price went from a low point around $1.12 to briefly over $6.47 in the past 52 weeks, though shares have since pulled back to $3.22. OPK market cap has remained high, hitting $2.13B at the time of writing, giving it a price-to-sales ratio of more than 2.

    OPKO Health Inc. has earlier started a Phase 2 trial with RAYALDEE as a treatment for mild-to-moderate COVID-19.  If we look at the recent analyst rating OPK, Piper Jaffray initiated coverage on OPK shares with an Overweight rating.

    Pacific Biosciences of California Inc. (NASDAQ: PACB)

    Pacific Biosciences of California Inc. (NASDAQ: PACB) last closed at $8.78, in a 52-week range of $2.20 to $8.38. Analysts have a consensus price target of $6.50. Pacific Biosciences of California Inc. (PACB) has announced it has appointed Susan G. Kim as Chief Financial Officer. The decision is effective as of September 28, 2020. Susan has joined the company at a time when there are various growth opportunities for the company.

    Bionano Genomics Inc. (NASDAQ: BNGO)

    Bionano Genomics Inc. (NASDAQ: BNGO) stock soar by 0.79% to $0.64. The most recent rating by Oppenheimer, on April 08, 2020, is at an Outperform. Bionano Genomics Inc. (BNGO) will participate in the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit. the summit is scheduled to take place virtually on September 21-23, 2020. This company market capitalization has remained high, hitting $90.45 million at the time of writing.

    Illumina Inc. (NASDAQ: ILMN)

    Illumina Inc. (NASDAQ: ILMN) shares headed falling, lower as much as -0.60%. The most recent rating by UBS, on September 22, 2020, is at a Neutral. Illumina Inc. (ILMN) has officially revealed an agreement to buy cancer-testing company Grail for about $8 billion in cash and stock. This company market capitalization has remained high, hitting $39.54 billion at the time of writing.

    Precipio Inc. (NASDAQ: PRPO)

    Precipio Inc. (NASDAQ: PRPO) shares headed rising, higher as much as 2.63%. Precipio Inc. has revealed that it has introduced its HemeScreen AML (Acute Myeloid Leukemia) panel both clinically in its CLIA laboratory, and as part of its HemeScreen product offering. This company market capitalization has remained high, hitting 37.42 million at the time of writing.

    Fulgent Genetics Inc. (NASDAQ: FLGT)

    Fulgent Genetics Inc. (NASDAQ: FLGT) stock soar by 7.08% to $40.25. The most recent rating by Oppenheimer, on August 20, 2020, is at an Outperform. Fulgent Genetics Inc. (FLGT) will replace Garrett Motion Inc. (GTX) in the S&P SmallCap 600 effective before the opening of trading on Friday, September 25. This company’s market capitalization has remained high, hitting $821.10 million at the time of writing.

    Fluidigm Corporation (NASDAQ: FLDM)

    Fluidigm Corporation (NASDAQ: FLDM) fall -1.29% after losing more than -$0.11 on Tuesday. In the past 52-weeks of trading, this company’s stock fluctuated between the low range of $1.17 and a high range of $12.45. It has moved up 595.73% from its 52-weeks low and moved down -34.62% from its 52-weeks high. Looking at its liquidity it has a current ratio of 2.00. This company’s market capitalization has remained high, hitting $523.91 million at the time of writing.

    Invitae Corporation (NYSE: NVTA)

    Invitae Corporation (NYSE: NVTA) last closed at $43.10, in a 52-week range of $7.41 to $40.96. Analysts have a consensus price target of $36.25. Invitae Corporation (NVTA) has moved up 475.19% from its 52-weeks low and moved down -2.16% from its 52-weeks high. Looking at its liquidity it has a current ratio of 3.70. This company’s market capitalization has remained high, hitting $5.56 billion at the time of writing.

    HTG Molecular Diagnostics Inc. (NASDAQ: HTGM)

    HTG Molecular Diagnostics Inc. (NASDAQ: HTGM) fall -8.01% after losing more than -$0.03 on Tuesday. HTG Molecular Diagnostics Inc. (HTGM) share price went from a low point around $0.27 to briefly over $0.99 in the past 52 weeks, though shares have since pulled back to $0.32. HTG Molecular Diagnostics Inc. market cap has remained high, hitting $22.70 million at the time of writing

    Co-Diagnostics Inc. (NASDAQ: CODX)

    Co-Diagnostics Inc. (NASDAQ: CODX) last closed at $14.93, in a 52-week range of $0.85 to $30.99. Co-Diagnostics Inc. (CODX) has moved up 1567.08% from its 52-weeks low and moved down -54.47% from its 52-weeks high. Looking at its liquidity it has a current ratio of 11.60. This company’s market capitalization has remained high, hitting $404.90 million at the time of writing.

  • Top Gainers as Earnings Drive Market Momentum

    Top Gainers as Earnings Drive Market Momentum

    The stock markets are up this afternoon, with the NASDAQ, Dow, and S&P 500 all in the green. This comes as investors await earnings of several major corporations after markets close.  Some of the companies that will release their earnings after markets are Disney, Beyond Meat, and Nikola. Expectations are high that if these companies record good results, it could be a signal to economic resilience despite the coronavirus.

    The markets are also driven by optimism that democrats and republicans are moving closer to a deal on a COVID-19 economic bailout. Yesterday, House Speaker Nancy Pelosi met with the White House Chief of Staff Mark Meadows and Senate Minority Leader Chuck Schumer to discuss unemployment benefits.  In this environment of increased optimism, there are stocks that are gaining by very high margins. Some of the top gainers this afternoon are as below:

    Zovio Inc [NASDAQ:ZVO]

    Zovio Inc is a top gainer this afternoon and is up by 22.85%.  The stock’s rally comes after the company reported strong Q2 results. The company reported that Q2 earnings stood at $0.24, beating analysts’ consensus estimates of $0.11 by 118.18%. The company reported that its non-GAAP net income rose to $8 million compared to a loss of $4.6 million that it reported in Q2 of 2019 when it had a non-GAAP income of $4.6 million. The company attributed its strong performance to a strong enrollment that beat expectations.  It also attributed the results to increased innovation in its software services.  CEO Andrew Clark stated that the firm was working with the University of Arizona to create an entity that will be powered by Zovio’s technologies. With such innovation and continued resilience in a pandemic, this stock remains a must-watch in the near-term.

    iRhythm Technologies Inc [NASDAQ:IRTC]

    iRhythm is another top performer this afternoon and is up by 26% at the time of writing. It’s upside momentum follows the company’s comments on Medicare and Medicaid proposed schedule for 2021. The company noted that the proposed rule that was set yesterday doesn’t include all the needed information, more specifically the Practice Expense RVU. iRhythm added that it would offer additional information based on the details provided by the CMS.

    Precipio Inc [NASDAQ:PRPO]

    Precipio Inc is another top gainer this afternoon and is up by over 30%. Its huge gains come after the company announced that it had launched antibody tests for COVID-19 in its labs. It stated that physicians will be in a position to do tests by simply drawing a blood sample from the patient.  CEO Ilan Danieli stated that the company was committed to making moves that will drive up customer and shareholder value.

  • Top 3 Stocks to Watch As Weak GDP Numbers Sink Markets

    Top 3 Stocks to Watch As Weak GDP Numbers Sink Markets

    The markets continue to trade in negative territory, due to the weak GDP economic data released earlier in the day.  The data is indicative of an economy that has been significantly hit by the COVID-19 pandemic. Given that there is no vaccine or cure available, it indicates that in the near-term, demand could remain low, and most companies might continue reporting lower financial numbers.

    Key indices are already in the red, with Dow 30 taking the biggest hit to trade lower by over 1%. However, even in this environment, there are stocks that are in significant gains. Some of the biggest gainers this afternoon are as below:

    Taoping Inc [NASDAQ:TAOP]

    Taoping Inc is one of the biggest gainers this afternoon and is up over 400%. This stock’s massive gains come after the company announced that it had upgraded its Taoping Smart Cloud platform and that it was now in the market. The company stated that the upgraded platform has been optimized to handle transaction systems, data monitoring, and ad publishing among other features.

    The company added that with the platform, it was in a position to offer better user experience and flexibility. The kicker is that the platform will help the company expand its partner model. CEO Jianghuai Lin has stated that the platform will help boost the company’s cash flows by a significant margin.

    Precipio Inc [NASDAQ:PRPO]

    This is another big gainer in the day and is up by over 290%. This rally follows the company’s announcement that it had launched a commercial COVID-19 antibody test. The company’s management stated that it had entered into a partnership with ADS Biotech for the distribution of COVID-19 serology antibody tests. The company further stated that it will do a test-run in August. CEO Ilan Danieli stated that the company was happy with the partnership and that it would help with the distribution of the test, both in the U.S and globally.

    DIRTT Environment Solutions Ltd [NASDAQ:DRTT]

    DIRTT Environment Solutions Ltd is another top gainer this afternoon and is up by over 60%. This comes after the company reported strong Q2 financial results.

    The company stated that revenues for the quarter stood at $42.2 million. It also reported gross profit margins of 33.7% and a cash balance of $44.6 million. The company’s management stated that the strong results were the result of the continuous implementation of its strategic plan. CEO Herman Miller stated that they were looking to further strengthen their commercial capabilities. He added that early in the month, they launched Make Space for Possibilities™, a strategic marketing campaign for this goal.